Tomasso Jun 1, 2023:

place to look maybe.. not my specialty...https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249303/ usually they have a similar text in other languages.,,,,NT50 was 8·2, 5·5 and 16·8 folds lower against Beta, Mu, and Omicron variants, respectively, in comparison with NT50 against reference G614 virus. In contrast, in subjects previously immunized with CVnCoV such difference was 2·6, 2·4 and 4·7 folds against Beta, Mu, and Omicron variants. Furthermore, neutralizing potency against Beta and Mu was above 1:1000 NT50 and above 1:500 against Omicron in the test group, which is about tenfold that found in the control group EU https://ec.europa.eu/health/documents/community-register/202... page 14 Ανοσογονικότητα σε συμμετέχοντες ηλικίας 18 ετών και άνω – μετά την αναμνηστική δόση (τρίτη δόση)
Η αποτελεσματικότητα μιας αναμνηστικής δόσης του Comirnaty βασίστηκε στην αξιολόγηση των
τίτλων εξουδετερωτικών αντισωμάτων στο 50% (NT50) έναντι του SARS-CoV-2 (USA_WA1/2020).
Στη μελέτη 2, οι αναλύσεις των NT50